BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roessler S, Budhu A, Wang XW. Deciphering cancer heterogeneity: the biological space. Front Cell Dev Biol. 2014;2:12. [PMID: 25364720 DOI: 10.3389/fcell.2014.00012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuan LT, Chang JH, Lee HL, Yang YC, Su SC, Lin CL, Yang SF, Chien MH. Genetic Variants of lncRNA MALAT1 Exert Diverse Impacts on the Risk and Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma. J Clin Med 2019;8:E1406. [PMID: 31500187 DOI: 10.3390/jcm8091406] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
2 Li W, Zhou Y, Wu Z, Shi Y, Tian E, Zhu Y, Wang T, Dou W, Meng X, Chen M, Zhai B, Zhu D. Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy. Front Pharmacol 2021;12:724306. [PMID: 34790117 DOI: 10.3389/fphar.2021.724306] [Reference Citation Analysis]
3 Itzel T, Spang R, Maass T, Munker S, Roessler S, Ebert MP, Schlitt HJ, Herr W, Evert M, Teufel A. Random gene sets in predicting survival of patients with hepatocellular carcinoma. J Mol Med (Berl) 2019;97:879-88. [PMID: 31001651 DOI: 10.1007/s00109-019-01764-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhang H, Ye ZL, Yuan ZG, Luo ZQ, Jin HJ, Qian QJ. New Strategies for the Treatment of Solid Tumors with CAR-T Cells. Int J Biol Sci 2016;12:718-29. [PMID: 27194949 DOI: 10.7150/ijbs.14405] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
5 Wang BG, Xu Q, Lv Z, Fang XX, Ding HX, Wen J, Yuan Y. Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: A case-control study. World J Gastroenterol 2018; 24(23): 2482-2490 [PMID: 29930469 DOI: 10.3748/wjg.v24.i23.2482] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
6 Giannelli G, Koudelkova P, Dituri F, Mikulits W. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65:798-808. [PMID: 27212245 DOI: 10.1016/j.jhep.2016.05.007] [Cited by in Crossref: 209] [Cited by in F6Publishing: 227] [Article Influence: 34.8] [Reference Citation Analysis]
7 Krewski D, Bird M, Al-Zoughool M, Birkett N, Billard M, Milton B, Rice JM, Grosse Y, Cogliano VJ, Hill MA, Baan RA, Little J, Zielinski JM. Key characteristics of 86 agents known to cause cancer in humans. J Toxicol Environ Health B Crit Rev 2019;22:244-63. [PMID: 31637961 DOI: 10.1080/10937404.2019.1643536] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Wang XW, Thorgeirsson SS. The biological and clinical challenge of liver cancer heterogeneity. Hepat Oncol 2014;1:349-53. [PMID: 30190968 DOI: 10.2217/hep.14.18] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
9 Cong WM, Bu H, Chen J, Dong H, Zhu YY, Feng LH, Chen J, Committee G. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol 2016; 22(42): 9279-9287 [PMID: 27895416 DOI: 10.3748/wjg.v22.i42.9279] [Cited by in CrossRef: 130] [Cited by in F6Publishing: 136] [Article Influence: 21.7] [Reference Citation Analysis]